Sildenafil citrate by XOMA Royalty for Female Hypoactive Sexual Desire Disorder: Likelihood of Approval

Sildenafil citrate is under clinical development by XOMA Royalty and currently in Phase II for Female Hypoactive Sexual Desire Disorder.

Pharmaceutical Process Automation and Equipment

Technological advances in automation and robotics are enabling the pharmaceutical industry to increase the speed and accuracy of their processes such as filling, packaging and

May 22, 2024

Exploring the impact of xylazine on wound care needs

The animal tranquilizer xylazine is increasingly found in the illicit opioid supply nationwide, leading to severe wounds among people who use drugs. New research led

August 22, 2024

Bacteriophage-derived lysin could be used to target odor-causing bacteria in armpits

Body odor from the armpits comes from bacteria metabolizing sweat produced by the apocrine glands. These bacteria are native to our skin, but the odors

April 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.